Price T Rowe Associates Inc. MD raised its position in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 83.4% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,399,372 shares of the company's stock after purchasing an additional 1,091,416 shares during the period. Price T Rowe Associates Inc. MD owned approximately 1.00% of HCA Healthcare worth $829,104,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently bought and sold shares of HCA. Cheviot Value Management LLC acquired a new stake in HCA Healthcare during the 1st quarter worth approximately $26,000. Atwood & Palmer Inc. bought a new stake in HCA Healthcare in the 1st quarter valued at approximately $28,000. Bartlett & CO. Wealth Management LLC lifted its stake in HCA Healthcare by 888.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock valued at $31,000 after acquiring an additional 80 shares in the last quarter. ORG Partners LLC lifted its stake in HCA Healthcare by 344.0% in the 1st quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after acquiring an additional 86 shares in the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its stake in HCA Healthcare by 75.8% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
HCA has been the subject of several recent research reports. Bank of America cut HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price target for the company. in a research report on Wednesday, July 16th. Stephens raised HCA Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Wolfe Research cut HCA Healthcare from an "outperform" rating to a "peer perform" rating in a report on Monday, July 28th. Finally, JPMorgan Chase & Co. lifted their price target on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a report on Monday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and nine have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $398.58.
Get Our Latest Report on HCA Healthcare
HCA Healthcare Stock Performance
HCA traded up $0.61 on Friday, reaching $404.87. The company had a trading volume of 1,081,188 shares, compared to its average volume of 1,326,629. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market cap of $94.74 billion, a P/E ratio of 17.02, a P/E/G ratio of 1.27 and a beta of 1.39. The company's fifty day moving average is $373.91 and its 200 day moving average is $354.23. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.86 and a current ratio of 0.98.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same period last year, the firm earned $5.50 earnings per share. HCA Healthcare's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be paid a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's payout ratio is 12.11%.
About HCA Healthcare
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Further Reading
Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access